Aromasin

The International Breast Cancer Study Group ( IBCSG ) has presented results of the randomized phase III SOFT trial at...


The International Breast Cancer Study Group ( IBCSG ) has presented results of the randomized phase III SOFT clinical trial...


The American Society of Clinical Oncology ( ASCO ) issued a newly updated clinical practice guideline on pharmacological prevention interventions...


Aromatase inhibitors carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of...


The largest study in the world of treatments for postmenopausal, hormone positive breast cancer has shown that patients who continue...


Osteoporosis is a growing concern among breast tumor survivors, because certain cancer drugs can cause bone loss.A new study has...


Osteoporosis is a growing concern among breast tumor survivors, because certain cancer drugs can cause bone loss.A new study has...


Two separate meta-analyses of clinical trials that tested Tamoxifen ( Nolvadex ) against aromatase inhibitors in postmenopausal women with early...


Two separate meta-analyses of clinical trials that tested Tamoxifen ( Nolvadex ) against aromatase inhibitors in postmenopausal women with early...


Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small...


Hormone sensitive postmenopausal early breast cancer patients who switched to Exemestane ( Aromasin ) after 2 to 3 years...


Breast tumor specialists cautioned doctors of the risks in prescribing vaginal oestrogen to breast cancer patients being treated with the...


Hormone sensitive postmenopausal early breast cancer patients who switched to Exemestane ( Aromasin ) after 2 to 3 years...


New data from the Intergroup Exemestane Study ( IES ) showed that hormone sensitive postmenopausal early breast cancer patients who...


The FDA ( U.S. Food and Drug Administration ) approved Aromasin ( Exemestane tablets ) for adjuvant treatment of postmenopausal...